Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Shorter radiation blasts aim to control rare skin cancer

NCT ID NCT05100095

First seen Jan 06, 2026 · Last updated Jun 10, 2026 · Updated 17 times

Summary

This study tests a shorter, higher-dose radiation schedule (hypofractionated) for people with Merkel cell carcinoma, a rare skin cancer. About 52 participants who have had surgery but no distant spread will receive radiation to the tumor site and nearby lymph nodes. The goal is to see if this approach controls cancer for at least 2 years while being more convenient and less harmful to the immune system.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MERKEL CELL CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • M D Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

cutaneous neuroendocrine carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.